Neuropeptide Y receptor antagonists in obesity

By Gehlert D.R.   Hipskind P.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1827-1838

Informa Healthcare

Access to resources Recommend Favorite

Recent developments with neuropeptide Y receptor antagonists

By Lundberg J.M.   Modin A.   Malmstrom R.E.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 301-304

Elsevier

Access to resources Recommend Favorite

Pharmacology of neuropeptide Y receptor antagonists - Focus on cardiovascular functions

By Malmstrom R.E.  

European Journal of Pharmacology, Vol. 447, Iss. 1, 2002-06 ,pp. : 11-30

Elsevier

Access to resources Recommend Favorite

GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y 1 receptor antagonists and neuropeptide Y Y 4 receptor agonists

By Parker E.M.   Babij C.K.   Balasubramaniam A.   Burrier R.E.   Guzzi M.   Hamud F.   Gitali Mukhopadhyay   Rudinski M.S.   Tao Z.   Tice M.   Xia L.   Mullins D.E.   Salisbury B.G.  

European Journal of Pharmacology, Vol. 349, Iss. 1, 1998-05 ,pp. : 97-105

Elsevier

Access to resources Recommend Favorite

Dihydropyrimidinone derivatives as neuropeptide Y antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 3, 1999-03 ,pp. : 321-325

Informa Healthcare

Access to resources Recommend Favorite